Similar Search Results

Chapter Twelve. Markets for Pharmaceutical Products

Scott Morton, Fiona; Kyle, Margaret - In: Handbook of health economics : volume 2, (pp. 763-823). 2011

This chapter describes the market for pharmaceuticals, which exceeded $500 million in sales in 2010. The industry is …

Persistent link: https://www.econbiz.de/10014025576

More cost-sharing, less cost? : evidence on reference price drugs

Herr, Annika; Stühmeier, Torben; Wenzel, Tobias - In: Health economics 32 (2023) 2, pp. 413-435

Persistent link: https://www.econbiz.de/10014266816

Generics and new goods in pharmaceutical price indexes

Griliches, Zvi; Cockburn, Iain - 1993

Persistent link: https://www.econbiz.de/10000884439

Generics and new goods in pharmaceutical price indexes

Griliches, Zvi; Cockburn, Iain - 1993

Persistent link: https://www.econbiz.de/10000857446

Competition in off-patent drug markets : issues, regulation and evidence

Kanavos, Panos; Costa-Font, Joan; Seeley, Elizabeth - In: Economic policy : a European forum 55 (2008), pp. 499-544

Persistent link: https://www.econbiz.de/10003741151

Drug competition and voluntary exit

Virabhak, Suchin; Sohn, Wook - In: Economics letters 101 (2008) 1, pp. 34-37

Persistent link: https://www.econbiz.de/10003787448

Can health insurance coverage explain the generic competition paradox?

Ferrara, Ida; Kong, Ying - In: Economics letters 101 (2008) 1, pp. 48-52

Persistent link: https://www.econbiz.de/10003787460

India's product patent protection regime : less or more of "pills for the poor"?

Gehl Sampath, Padmashree (contributor) - 2006

Persistent link: https://www.econbiz.de/10003328268

Can branded drugs benefit from generic entry? : the role of detailing and price in switching to non-bioequivalent molecules

Gonzalez, Jorge; Sismeiro, Catarina; Dutta, Shantanu; … - In: International journal of research in marketing : IJRM ; … 25 (2008) 4, pp. 247-260

Persistent link: https://www.econbiz.de/10003793502

Physician dispensing and the choice between generic and brand-name drugs : do margins affect choice?

Rischatsch, Maurus; Trottmann, Maria - 2009

Many politicians blame physician dispensing (PD) to increase health care expenditure and to undermine independence of drug prescription and income leading to a suboptimal medication. Therefore, PD is not allowed in most OECD countries. In Switzerland, PD is allowed in some regions depending on...

Persistent link: https://www.econbiz.de/10003900934